FTC Blesses GTCR's $675M Purchase Of Sterigenics
The Federal Trade Commission on Tuesday granted an early termination of its antitrust review of Chicago private equity firm GTCR LLC's plan to buy Silverfleet Capital's medical device and pharmaceuticals sterilization...To view the full article, register now.
Already a subscriber? Click here to view full article